Skip to main content
. 2013 Jun 20;17(3):R117. doi: 10.1186/cc12789

Table 4.

Troponin, CK, and CK-MB levels at each time point in patients randomized to vasopressin or norepinephrine

Vasopressin group
median (1st, 3rd quartile), n 		Norepinephrine group
median (1st, 3rd quartile), n
Time Baseline 6 hours Day 2 Day 4 Baseline 6 hours Day 2 Day 4 P value
Troponin I (µg/L) 0.07
(0.0, 0.54)
48		 0.11
(0.0, 0.71)
44		 0.15
(0.0, 0.60)
39		 0.03
(0.0, 0.24)
35		 0.20
(0.0, 0.39)
44		 0.35
(0.10,0.70)
39		 0.21
(0.0, 0.60)
37		 0.14
(0.0, 0.43)
33		 0.230
Troponin T
(µg/L)		 0.06
(0.02, 0.09)
14		 0.06
(0.0, 0.14)
11		 0.03
(0.0, 0.09)
12		 0.00
(0.0, 0.02)
9		 0.01
(0.0, 0.42)
11		 0.06
(0.0, 0.38)
10		 0.07
(0.01, 0.35)
12		 0.13
(0.01, 0.39)
8		 0.360
CK
(U/L)		 204
(61, 487)
54		 208
(54, 435)
48		 190
(36, 452)
50		 69
(21, 189)
45		 184
(60, 309)
46		 192
(68, 438)
46		 147
(41, 296)
45		 46
(21, 222)
39		 0.985
CK-MB
(µg/L)		 4.0
(1.6, 6.9)
16		 3.0
(1.3, 6.0)
15		 5.0
(1.0, 16.0)
14		 1.4
(0.0, 3.1)
14		 4.3
(1.0, 8.0)
14		 2.6
(1.8, 17.2)
12		 4.7
(2.0, 16.0)
13		 1.9
(1.0, 6.0)
10		 0.396

Serum levels of troponin, creatine kinase (CK), and creatine kinase-MB (CK-MB) at each time point. P value is based on linear mixed-effects regression model and is for the null hypothesis of no difference in troponin/CK/CK-MB level between the treatment groups at 6 hours, day 2, and day 4, adjusted for baseline value. Outcome variables were log transformed if they were not normally distributed.